Kruti Shah
Kruti Shah has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Shwetal Bhatt
Department of Paediatrics, SSG Hospital, Vadodara, Gujarat, India
3 shared publications - Akshay Dwarka Baheti
Department of Radiodiagnosis, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
1 shared publication - Ashka Prajapati1 shared publication
- Badira Cheriyalinkal Parambil
Tata Memorial Centre
1 shared publication - Divya Dave1 shared publication
- Forest W. Arnold
Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Louisville, Louisville, KY, USA
1 shared publication
Latest Publications
- 4 August 2026
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 48 (7) , 313-322
Real World Outcomes of Metastatic Rhabdomyosarcoma in Children Treated With a Multimodal Protocol: A Single Center Experience
Background and Aims: Metastatic rhabdomyosarcoma (RMS) at diagnosis has poor outcomes. We audited these outcomes in children at a tertiary sarcoma unit. Methods: Children aged 15 years or younger with RMS at first diagnosis staged by FDG-PET CECT scan between January 2013 and December 2024 were retrospectively analyzed. Pulmonary, lymph node, and oligometastatic bone disease were treated with curative intent on a multimodal protocol comprising chemotherapy and local therapy to the primary and metastatic sites. Results: Of 126 patients, 19% had isolated pulmonary, 81% had extrapulmonary metastases, with bone marrow involvement in 3.1%. After neoadjuvant chemotherapy in 73 patients (treated with curative intent), 74% had complete response (CR), 19% partial response (PR), 4% stable disease, and 3% progression. Local therapy to the primary was given to 68 patients (radiotherapy: 70.5%, surgery+radiotherapy: 22.1%, surgery: 7.3%), and metastatic sites were treated in 61.8%. At a median follow-up of 11 months (IQR: 3.31, 20.8), 2-year EFS and OS probabilities were 30.2% (95% CI: 19.8-41.2) and 44.4% (95% CI: 32.5-55.6), respectively; survival did not differ by metastasis site. Complete response at primary (HR: 0.09, 95% CI: 0.30-0.29, P P =0.008), and bone marrow involvement (HR: 1.98, 95% CI: 1.01-3.91, P =0.050) affected EFS. Conclusions: Despite multimodal therapy, metastatic rhabdomyosarcoma continues to have poor outcomes. Tumor size ≥3.3 cm in oligometastatic disease and bone marrow involvement predicted poor prognosis, while complete primary site response after neoadjuvant chemotherapy was associated with improved survival.
- 4 August 2026
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 48 (7) , 313-322
Real World Outcomes of Metastatic Rhabdomyosarcoma in Children Treated With a Multimodal Protocol: A Single Center Experience
Background and Aims: Metastatic rhabdomyosarcoma (RMS) at diagnosis has poor outcomes. We audited these outcomes in children at a tertiary sarcoma unit. Methods: Children aged 15 years or younger with RMS at first diagnosis staged by FDG-PET CECT scan between January 2013 and December 2024 were retrospectively analyzed. Pulmonary, lymph node, and oligometastatic bone disease were treated with curative intent on a multimodal protocol comprising chemotherapy and local therapy to the primary and metastatic sites. Results: Of 126 patients, 19% had isolated pulmonary, 81% had extrapulmonary metastases, with bone marrow involvement in 3.1%. After neoadjuvant chemotherapy in 73 patients (treated with curative intent), 74% had complete response (CR), 19% partial response (PR), 4% stable disease, and 3% progression. Local therapy to the primary was given to 68 patients (radiotherapy: 70.5%, surgery+radiotherapy: 22.1%, surgery: 7.3%), and metastatic sites were treated in 61.8%. At a median follow-up of 11 months (IQR: 3.31, 20.8), 2-year EFS and OS probabilities were 30.2% (95% CI: 19.8-41.2) and 44.4% (95% CI: 32.5-55.6), respectively; survival did not differ by metastasis site. Complete response at primary (HR: 0.09, 95% CI: 0.30-0.29, P P =0.008), and bone marrow involvement (HR: 1.98, 95% CI: 1.01-3.91, P =0.050) affected EFS. Conclusions: Despite multimodal therapy, metastatic rhabdomyosarcoma continues to have poor outcomes. Tumor size ≥3.3 cm in oligometastatic disease and bone marrow involvement predicted poor prognosis, while complete primary site response after neoadjuvant chemotherapy was associated with improved survival.
- Open Access
- 5 June 2025
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 54 (2) , 159-161
A novel case of neonatal diabetes as an isolated part of immune dysregulation, polyendocrinopathy, X‐linked (IPEX) syndrome
- 5 June 2025
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 54 (2) , 159-161
Open AccessA novel case of neonatal diabetes as an isolated part of immune dysregulation, polyendocrinopathy, X‐linked (IPEX) syndrome
- Open Access
- 5 June 2025
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 54 (2) , 171-174
Homozygous mutations in ALDH7A1 gene causing pyridoxine dependent epilepsy: Phenotype and genotype of three patients
- 5 June 2025
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 54 (2) , 171-174
Open AccessHomozygous mutations in ALDH7A1 gene causing pyridoxine dependent epilepsy: Phenotype and genotype of three patients
- Open Access
- 5 June 2025
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 54 (2) , 168-170
A case of Niemann Pick disease type-A with associated neonatal thrombosis
- 5 June 2025
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 54 (2) , 168-170
Open AccessA case of Niemann Pick disease type-A with associated neonatal thrombosis
- Open Access
- 6 May 2024
- Published by MedCrave Group Kft. in Journal of Pediatrics & Neonatal Care
- Vol. 14 (2) , 105-107
Clinical profile, laboratory parameters and management outcomes in an eight-year-old female with childhood lupus nephritis
Systemic lupus erythematosus (SLE) is a chronic, multisystem, autoimmune disorder characterized by widespread inflammation of connective tissues affecting the skin, joints, kidneys, heart, lungs and nervous system. SLE is most often diagnosed in women during the second to fourth decades of life, but 15-20% cases are found in childhood. Renal involvement occurs in the majority of childhood onset SLE (cSLE) patients and is often fatal and hence constitutes an important determinant of prognosis. Multidisciplinary care is necessary for children with lupus nephritis in terms of immunosuppressive regimes with a common goal of achieving and maintaining renal remission. Despite a low prevalence rate of cSLE, it manifests with fatal complications like lupus nephritis in majority of cases. Renal biopsy is gold standard for staging of lupus nephritis, thus, deciding the modality of management and prognostication of cSLE.
- 6 May 2024
- Published by MedCrave Group Kft. in Journal of Pediatrics & Neonatal Care
- Vol. 14 (2) , 105-107
Open AccessClinical profile, laboratory parameters and management outcomes in an eight-year-old female with childhood lupus nephritis
Systemic lupus erythematosus (SLE) is a chronic, multisystem, autoimmune disorder characterized by widespread inflammation of connective tissues affecting the skin, joints, kidneys, heart, lungs and nervous system. SLE is most often diagnosed in women during the second to fourth decades of life, but 15-20% cases are found in childhood. Renal involvement occurs in the majority of childhood onset SLE (cSLE) patients and is often fatal and hence constitutes an important determinant of prognosis. Multidisciplinary care is necessary for children with lupus nephritis in terms of immunosuppressive regimes with a common goal of achieving and maintaining renal remission. Despite a low prevalence rate of cSLE, it manifests with fatal complications like lupus nephritis in majority of cases. Renal biopsy is gold standard for staging of lupus nephritis, thus, deciding the modality of management and prognostication of cSLE.
- 10 June 2022
- Published by Sciencedomain International
- p. 142-149
Evaluating the Stillbirth Rate and Risk Factors at Zanana Hospital and P. D. U. Medical College, Rajkot: An One Year Observational Study
Stillbirths constitute a major part of perinatal death, and India has the highest absolute number of stillbirths. Women in the most deprived groups are at the highest risk for stillbirths, for example poorer women, with little education, those living in rural areas and not currently working. The focus of this research was to assess our institute's stillbirth rate, as well as the aetiology and risk factors for stillbirths. During the study period of one year, all stillbirths delivered at or above 28 weeks of gestation or weighing more over 1000gms in P.D.U. Medical College and Hospital, Rajkot were included. The institute's stillbirth rate was investigated. Indicators of socio-economic deprivation were strongly associated with increase in stillbirths. 70% cases belonged to rural region and 48% cases were referral cases. 67.2% stillbirths were found in multigravida women . 57.01% stillborn babies were males, 34.71% of stillborns had extremely low birth weight and were pre-term. 54.78% stillborns were macerated. Aetiology of stillbirth was unknown in 24.8% cases. Antepartum haemorrhage contributed 19% cases, asphyxia -16.8% cases and pre-eclampsia-12.1% cases of stillbirth, in our study. The reduction of stillbirths can be aided by focusing on modifiable risk factors, thorough screening, prenatal and intrapartum supervision, and timely referral to a tertiary care center.
- 10 June 2022
- Published by Sciencedomain International
- p. 142-149
Evaluating the Stillbirth Rate and Risk Factors at Zanana Hospital and P. D. U. Medical College, Rajkot: An One Year Observational Study
Stillbirths constitute a major part of perinatal death, and India has the highest absolute number of stillbirths. Women in the most deprived groups are at the highest risk for stillbirths, for example poorer women, with little education, those living in rural areas and not currently working. The focus of this research was to assess our institute's stillbirth rate, as well as the aetiology and risk factors for stillbirths. During the study period of one year, all stillbirths delivered at or above 28 weeks of gestation or weighing more over 1000gms in P.D.U. Medical College and Hospital, Rajkot were included. The institute's stillbirth rate was investigated. Indicators of socio-economic deprivation were strongly associated with increase in stillbirths. 70% cases belonged to rural region and 48% cases were referral cases. 67.2% stillbirths were found in multigravida women . 57.01% stillborn babies were males, 34.71% of stillborns had extremely low birth weight and were pre-term. 54.78% stillborns were macerated. Aetiology of stillbirth was unknown in 24.8% cases. Antepartum haemorrhage contributed 19% cases, asphyxia -16.8% cases and pre-eclampsia-12.1% cases of stillbirth, in our study. The reduction of stillbirths can be aided by focusing on modifiable risk factors, thorough screening, prenatal and intrapartum supervision, and timely referral to a tertiary care center.
- 1 March 2012
- Published by Wolters Kluwer Health
- Vol. 72 (3) , 691-695
Evaluating contemporary antibiotics as a risk factor for Clostridium difficile infection in surgical trauma patients
With most Clostridium difficile infections (CDI) occurring after exposure to antimicrobial treatment, specific antibiotics and duration of exposure were evaluated independently for increased risk of CDI in surgical patients. A retrospective, case-control design was used to study surgical inpatients. The case group had a positive Clostridium difficile toxin assay, whereas the control group did not. Four antibiotics had a risk that was statistically significant for causing CDI in surgical patients: cefepime (odds ratio [OR], 5.7; 95% confidence interval [CI], 1.7–19.1; p = 0.0044), imipenem/cilastatin (OR, 3.2; 95% CI, 1.2–8.9; p = 0.0388), piperacillin/tazobactam (OR, 2.4; 95% CI, 1.3–4.5; p = 0.0067), and vancomycin (OR, 1.9; 95% CI, 1.0–3.5; p = 0.0439). Exposure longer than 7 days to cefepime (p = 0.0006), piperacillin/tazobactam (p = 0.0021), and imipenem/cilastatin (p = 0.0171) also increased risk for development of CDI. The use of cefepime, imipenem/cilastatin, piperacillin/tazobactam, and vancomycin and the use of multiple classes of antibiotics for at least 7 days significantly increased the risk of CDI in surgical inpatients.
- 1 March 2012
- Published by Wolters Kluwer Health
- Vol. 72 (3) , 691-695
Evaluating contemporary antibiotics as a risk factor for Clostridium difficile infection in surgical trauma patients
With most Clostridium difficile infections (CDI) occurring after exposure to antimicrobial treatment, specific antibiotics and duration of exposure were evaluated independently for increased risk of CDI in surgical patients. A retrospective, case-control design was used to study surgical inpatients. The case group had a positive Clostridium difficile toxin assay, whereas the control group did not. Four antibiotics had a risk that was statistically significant for causing CDI in surgical patients: cefepime (odds ratio [OR], 5.7; 95% confidence interval [CI], 1.7–19.1; p = 0.0044), imipenem/cilastatin (OR, 3.2; 95% CI, 1.2–8.9; p = 0.0388), piperacillin/tazobactam (OR, 2.4; 95% CI, 1.3–4.5; p = 0.0067), and vancomycin (OR, 1.9; 95% CI, 1.0–3.5; p = 0.0439). Exposure longer than 7 days to cefepime (p = 0.0006), piperacillin/tazobactam (p = 0.0021), and imipenem/cilastatin (p = 0.0171) also increased risk for development of CDI. The use of cefepime, imipenem/cilastatin, piperacillin/tazobactam, and vancomycin and the use of multiple classes of antibiotics for at least 7 days significantly increased the risk of CDI in surgical inpatients.